Mark Elliott Boulding - EXEC. VP AND CLO at Ptc Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Exec. Vp And Clo
Stock Symbol
PTCT on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Mark Elliott Boulding - trading volume in the past year for Ptc Therapeutics, Inc.

Holdings reported by Mark Elliott Boulding for Ptc Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 104K $8.02M $77.18 Nov 17, 2025 Direct
Stock Option (Right to Buy) 25.3K $0 $27.05 Nov 17, 2025 Direct Common Stock

Transactions reported by Mark Elliott Boulding for Ptc Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.